Membrane Associated Guanylate Kinase, WW and PDZ Domain Containing 2 (MAGI2) Peptide
-
- Target See all MAGI2 products
- MAGI2 (Membrane Associated Guanylate Kinase, WW and PDZ Domain Containing 2 (MAGI2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EEEEEERPVV NGNGVVVTPE SSEHEDKSAG ASGEMPSQPY PAPVYSQPEE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGI2 antibody,
Alternative Names: MAGI2 control peptide, MAGI2 antibody Blocking Peptide, Anti-MAGI2 Blocking Peptide, membrane associated guanylate kinase, WW and PDZ domain containing 2 Blocking Peptide, ACVRIP1 Blocking Peptide, AIP1 Blocking Peptide, ARIP1 Blocking Peptide, MAGI-2 Blocking Peptide, SSCAM Blocking Peptide, MAGI2, MAGI-2, MAGI 2, MAGI-2 Blocking Peptide, MAGI 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MAGI2 (Membrane Associated Guanylate Kinase, WW and PDZ Domain Containing 2 (MAGI2))
- Background
- The protein encoded by this gene interacts with atrophin-1. Atrophin-1 contains a polyglutamine repeat, expansion of which is responsible for dentatorubral and pallidoluysian atrophy. This encoded protein is characterized by two WW domains, a guanylate kinase-like domain, and multiple PDZ domains. It has structural similarity to the membrane-associated guanylate kinase homologue (MAGUK) family.
- Molecular Weight
- 160 kDa
-